ASX
Chimeric Therapeutics Limited
CHM:ASX•Healthcare
Sensitive ASX Announcement
Second Dose Cohort Initiated in CLTX CAR T Phase 1 Trial
Published: 24/05/21, 08:54am (AEST)•2 pages